A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors
Conditions: Sarcoma; Carcinoma; Digestive Cancer; Breast Cancer; Lung Cancer; Brain Cancer; Melanoma; Gynecologic Cancer; Head and Neck Cancer; Kidney Cancer Intervention: Drug: Recombinant oncolytic herpes simplex virus type 1 (R130) Sponsors: Shanghai Yunying Medical Technology; Linyi Central Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials
Herpes Zoster Hospitalizations in Italy
Conditions: Herpes Zoster; Comorbidities and Coexisting Conditions Intervention: Other: Hospitalization Sponsors: University of L'Aquila; GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 19, 2023 Category: Research Source Type: clinical trials